UC Berkeley UC Berkeley Electronic Theses and Dissertations Title Development of a Breast Cancer Stem Cell Model and the Inhibitory Regulation of Small Molecule Phytochemicals on Various Stages of Human Breast Cancer Cells Permalink https://escholarship.org/uc/item/0fw3v9x3 Author Tin, Antony Shen Publication Date 2013 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California Development of a Breast Cancer Stem Cell Model and the Inhibitory Regulation of Small Molecule Phytochemicals on Various Stages of Human Breast Cancer Cells By Antony S. Tin II A dissertation submitted in partial satisfaction of the Requirements for the degree of Doctor of Philosophy In Endocrinology In the Graduate Division Of the University of California, Berkeley Committee in charge: Professor Gary L. Firestone, Chair Professor Jen-‐Chywan (Wally) Wang Professor Iswar K. Hariharan Spring 2013 ABSTRACT Development of a Breast Cancer Stem Cell Model and the Inhibitory Regulation of Small Molecule Phytochemicals on Various Stages of Human Breast Cancer Cells By Antony S. Tin II Doctor of Philosophy in Endocrinology University of California, Berkeley Professor Gary L Firestone, Chair The development of clinical breast cancer is a multistep process that manifests itself as a disease with various distinct phenotypes. At present, it is believed that a neoplastically-‐ transformed cell undergoes many heterogeneous changes and mutations before evolving into a tumorous or invasive breast cancer. Due to the heterogeneity of breast cancer, a single therapeutic strategy is rarely completely effective for all patients. Current therapeutic options such as hormone antagonists, radiation and chemotherapy have many deleterious side effects which demonstrates a need for a more efficacious therapy alternative that can not only target varying phenotypes but also ameliorates harsh side effects. In addition, it is essential to identify compounds that can slow the promotion of the disease from preneoplastic lesions to invasive breast cancer. This thesis details the generation of a novel breast cancer stem cell model and the molecular mechanism of two small molecule phytochemicals, indole-‐3-‐carbinol (I3C), and artemisinin, target breast cancer stem cells and luminal A, estrogen sensitive breast cancer, respectively. We show that ectopic expression of HER2, a member of the epidermal growth factor receptor family, in MCF-‐10AT preneoplastic mammary epithelial cells induces a phenotype with the molecular markers of breast cancer stem cells expression: CD44+/CD24-‐/ALDH-‐1+ with highly expressing levels of stem cell marker, nucleostemin. These cells are capable of forming tumorspheres in 3-‐D cultures, indicative of a population highly enriched with stem cells. Furthermore, as few as 30,000 cells are able to form viable mammary tumors in athymic mouse xenograft models. In breast cancer stem cells, I3C induces apoptosis by selectively targeting nucleostemin and activating the p53 apoptotic pathway. I3C induces the proteolytic degradation of Akt1 and thereby functionally inactivates MDM2. Loss of MDM2 phosphorylation and its subsequent inactivation frees p53 to induce apoptosis. Coupled with the activation of nucleostemin by I3C, nucleostemin sequesters MDM2 away from p53 further enhancing the apoptotic effect. Knockdown of nucleostemin prevents the I3C apoptotic effects, suggesting the selective role of I3C on breast cancer stem cells. Also, expressing constitutively active Akt1 or a dominant negative form of p53 overrides the I3C induced apoptotic effect, highlighting the specific Akt1/MDM2/p53 pathway modulated by I3C. The preclinical results implicate I3C as a novel anti-‐cancer agent that can selectively 1 target cancer stem cells especially given that I3C also increases MDM2-‐nucleostemin interactions and can reduce tumors volumes in vivo. We also show that artemisinin, derived from the sweet wormwood, Artemisia annua, ablates key G1 cell cycle regulators to induce growth arrest in luminal A, estrogen sensitive breast cancer as well as inhibit in vivo xenograft growth in athymic mice. Artemisinin is selective towards malignant cells, such as the MCF-‐7 breast cancer cell line since it is ineffective in arresting growth in nontumorigenic breast cell lines. Artemisinin exposed MCF-‐7 cells displayed ablated levels of cyclin-‐dependent kinases 2 and 4 (CDK), cyclin E, cyclin D as well as E2F1 at the protein 1 and mRNA level. Promoter deletion mapping and subsequent chromatin immunoprecipitation analyses revealed that downregulation of E2F1 resulted in inhibition of CDK2 of promoter activity. Additionally, constitutive expression of E2F1 reversed the growth arrest, CDK2 and cyclin E downregulation induced by artemisinin. 2 ACKNOWLEDGEMENTS I would like to thank Professor Gary Firestone for mentoring me on so many different levels throughout my tenure in graduate school. I will never forget that you took me in without hesitation after Professor Timiras passed away and willingly gave me a lab to call home. Gary, you have been more than a mentor to me, you have been a friend and a guide who has always encouraged me to think critically. You have provided me with the perfect balance of independence, while still given me direction and support. I am still learning valuable lessons from you about research and life and am looking forward to using all the skills you have taught me for the rest of academic and professional career. Thank you for always being there for me. I would especially like to thank my loving family for always supporting me and being there through everything. Daddy, you have always encouraged me to pursue my dreams and have given me the world. You showed me the true meaning of life and exposed me to so many different things. I can honestly say you provided me with all the creature comforts in life. After all the talks and advice you have given me, I am just starting to appreciate and understand the meaning of it all. Mommy, there are no words to express how much I love you and just knowing how much you believe in me has helped me get to where I am today. Ever since I was a baby, you have taught me to stand up for myself and cared for me in a way nobody else ever could. I know you always put me first and I cannot begin to express the way I feel for your tireless efforts. Pearl, I want to especially thank you for always calling me and being there for me on a moments notice. You have been my emotional support and have given me so much perspective by teaching me the bigger picture in life. I cannot imagine having a better older sister knowing how you paved the way for me in all aspects of my life. I want to say thank you from the bottom of my heart and I cannot stop thinking about how you used to save me your notes from high school so I could use it two years later or making sure that I kept my social life in check during college and helping me in my professional life after graduate school. You are the strongest person I know and knowing that you are there for me helps me sleep at night. You truly are an amazing person and I will never forget that. Julia, I want to thank you for taking care of me and raising me as your own son. I will always be your son and will always remember all things you did when raising me to keep me happy like take me to IHOP on my birthday and making me cucumbers to eat and our walks at lake Chabot. Shyam – I can’t express how much I appreciate everything you have done for me. Without you, I literally would not know what to do. You gave me my projects that have led me to my thesis and PhD and it all started because of you. I know I will use all the skills you have taught me and despite the nonstop drama, I wanted to thank you for being the voice inside my head telling me what to do but also keeping me sane and motivated to work. Kevin – You are the one that got me through grad school. I can never thank you enough for keeping me sane from team estrogen! I will never forget the time you helped me with all the PCRs right before the poster session or the crazy “adventures” at Granlibakken. It was great being with you in lab from the very start and you are one of the most thoughtful i people I know. I am so grateful to be able to call you my friend knowing you always have my back. I don’t know what to do now that I am leaving and won’t have you around to help me with all my math questions. Kalvin – We started together and now we are ending together! You are my brother from another mother. After all those late nights complaining about the work Shyam put on us has finally paid off for the both of us. Thank you for all your help and tireless effort to make the Ishikawa and MCF-‐7 Art project come to fruition. You are truly an amazing person and I know that you will be rewarded in all your endeavors. Anna – This is for you. You have been everything to me and to my life. I cannot imagine a world without you being there to support me mentally, emotionally, and physically. I will always think back to the first time I met you at USC and how I immediately knew that this would be the start of something epic. AT&T PARK. (ANNA TONY TIN PARK)! Without you, this thesis, my PhD would not be possible. You have played an integral part of my academic career and somehow everything always goes back to science. I will miss just getting a meal with you where we end up talking about the science behind every signaling pathway or how cells differentiate or what genes do what. I don’t think anyone else knows me better than you and can relate to me the way you have. You really changed my life for the better and helped keep me motivated in all aspects of my life. Everything from exercising and doing a marathon and triathlon, to turning me into a kimchi connoisseur where I now love Korean food more than Chinese food…this would not have happened without you. You are the most amazing person that I have ever met and I want you to know that you are the smartest, most caring, and selfless person I know. I was so proud of you graduated with honors and then when you got accepted into graduate school. You are a winner and I know that you will succeed in anything you put your mind to and that your dedication and sincerity will get you very far in life. You deserve to have it all and I have no doubt that you will be rewarded for all your hard work. I want to thank you for staying by my side for so long and enduring all the late nights, inconsistencies, contradictions and difficulties that you handle with grace and poise. In addition, I would also like to thank all the colleagues in the Firestone lab that has been some of my best of friends I have ever had. Besides all the help and input, you guys kept my life fun and I will never forget all our happy hour adventures and lunches. You were all sources of my inspiration. ii This work is dedicated to my uncle Pang Pen Sheng From the fond memories of playing with you in the park and riding the steam trains or hiking up the mountain to watch the view, I am constantly thinking about you. I miss you so much. You raised me as your own son and the unconditional love and support will forever inspire me. Thank you for always believing in me and even now still watching over me. ii i TABLE OF CONTENTS List of Figures ...….…………….….............……….………….………………………………………………………....v General Introduction ………………………………………………………..............…………………………...vii Chapter I Development of a novel model system to study breast cancer stem cells...……..................1 Abstract ……………………….......………………........................................…….......…………........2 Introduction…………………………….………………………………........……………………........ 3 Materials and Methods……………….………………………………….......………………….......5 Results.…………….….……………………………………………………………………………...........7 Discussion………………………………………………………………………………………........... 30 References…………………………………………………………………………………….........…. 32 Chapter II Essential role of nucleostemin in indole-‐3-‐carbinol anti-‐proliferative targeting of breast cancer stem cells…………………………………………………………………………………................ 35 Abstract………………………………………………………………………………………….............36 Introduction…………………………………………………………………………………...............37 Materials and Methods……………………………………………………………………............39 Results……………………………………………………………………………………………...........42 Discussion………………………………………………………………………………………............78 References………………………………………………………………………………………...........80 Chapter III Artemisinin antiproliferative response in human breast cancer cells requires the down-‐regulated expression of the E2F1 transcription factor and loss of E2F1-‐target cell cycle genes………………………………………………………………………………........................................82 Abstract………………………………………………………………………………………….............83 Introduction…………………………………………………………………………………...............84 Materials and Methods……………………………………………………………………............86 Results……………………………………………………………………………………………...........90 Discussion……………………………………………………………………………………….........125 References………………………………………………………………………………………........127 Chapter IV Conclusion and Future Directions...........................................................................................................131 Conclusion and Future Directions...............................................................................132 iv LIST OF FIGURES General Introduction Figures Figure 1: Classical model of tumor progression……………………………………..…....................ix Figure 2: The cancer stem cell model……………………………………..………………......................xii Figure 3: Phosphotyrosine interactome of the epidermal growth factor receptor kinase family…………………………………….……………………....................................…...xvi Figure 4: The HER2 signaling pathway………………………………………..……...….....................xix Figure 5: Indole-‐3-‐Carbinol (I3C)………………………….............……………..……...…..................xxii Figure 6: Postulated anticancer mechanism of action by artemisinin………….….......xxvi Chapter I Figures Figure 7: Characterization of CSC markers by HER2 overexpression in MCF-‐10AT cells……………………………………………..……………………………………..............................9 Figure 8: Quantification of cell surface marker CD44 and CD24…………..………..........…..12 Figure 9 Quantification of ALDH-‐1 activity in 10AT-‐Her2 and 10AT-‐Neo cells.............14 Figure 10: Formation of tumorspheres by 10AT-‐Her2 cells in vitro………………….............17 Figure 11: Comparing 10AT-‐Her2 tumorsphere forming efficiency..…..………….............…29 Figure 12: I3C inhibition of tumorsphere formation in 10AT-‐Her2 cells.…….............…… 22 Figure 13: I3C and 1-benzyl-I3C selectively disrupts cancer stem cell tumorsphere formation …………………………………………………………………………………............……24 Figure 14: Tumor-‐forming efficiency between 10AT-‐Her2 and 10AT-‐Neo cells .............27 Figure 15: I3C inhibition of 10AT-‐Her2 Tumor Xenografts….…………..…………................…29 Chapter II Figures Figure 16: I3C inhibits 10AT-‐Her2 cell proliferation.…………………………............…………....44 Figure 17: Flow cytometry analysis of the I3C induced apoptotic effects on 10AT-‐Her2 cells..........…………………..……………………......................................…………46 Figure 18: I3C induces PARP cleavage in 10AT-‐Her2 breast cancer stem cells….............48 Figure 19: I3C induced apoptotic response is mediated by p53…………………….................51 Figure 20: I3C induces nucleostemin-‐mdm2 interactions in cancer stem cells….............54 Figure 21: I3C releases p53 from its E3 ligase, MDM2 in cancer stem cells…….................56 Figure 22: I3C induced MDM2 translocation into the nucleus requires nucleostemin expression……………………………….………………….................................................………59 Figure 23: MDM2 translocates into the nucleus and colocalizes with nucleostemin foci upon I3C treatment…………………………........................................................………….....62 Figure 24: Nucleostemin knockdown diminishes I3C induced release of p53 from MDM2………………………………………………......................................................………….....65 Figure 25: Nucleostemin siRNA overrides the I3C induced apoptosis in cancer stem cells ………………………………………………………………………………….............................67 Figure 26: I3C downregulates Akt1 expression at the protein level ………...................……70 v
Description: